METHOD OF IMMUNOCORRECTION OF MAIN COURSE OF TREATMENT OF DESTRUCTIVE FORMS OF PULMONARY TUBERCULOSIS Russian patent published in 2013 - IPC A61K31/00 A61P7/04 A61P31/06 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to phthisiology and can be used with the purpose to increase efficiency of treatment of patients with destructive forms of pulmonary tuberculosis. For this purpose after relief of intoxication manifestations and absence of side effects thymaline in dose 40 mg is introduced to patient in paravasal way 5 days running. After that, 6 days after finishing its introduction, 3% solution of drug glutoxime is introduced in dose 2.0 ml for 10 days. Then, introduced is cycloferon in dose 0.25 g, two times per week until intensive stage of main course is over.

EFFECT: invention makes it possible to reduce terms of elimination of destructive changes in lungs and achieve cessation of mycobacteria release in patients with expressed secondary immunodeficiency.

1 ex